Advertisement
Study reveals viable alternative for patients with refractory disease
IV ketamine infusion is an option when conventional therapies fail to yield relief
Dr. Amit Anand shares his journey from a 1990s discovery to an ongoing randomized trial
Study combines the acute medication therapy with CAMS for long-term management
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Balancing rapid relief and convenient administration with highly regulated distribution
Cleveland Clinic to lead four-center, 400-patient randomized trial
Advertisement
Advertisement